iCD Research, Dec 2011, Pages: 51
Synopsis
ICD Research's "Genzyme Corporation: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview
Business Review, April 2010, Pages: 26
Synopsis
Business Review’s Genzyme Corporation contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.
Summary
This SWOT
Datamonitor, May 2011, Pages: 95
This analysis examines the historical and forecast performance for Genzyme in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis
Datamonitor, June 2011, Pages: 72
The Genzyme Corporation’s SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis
Datamonitor, Aug 2011, Pages: 27
Genzyme Corporation - SWOT Analysiscompany profile is the essential source for top-level company data and information. Genzyme Corporation - SWOT Analysis examines the company’s key business
GlobalData, Nov 2010, Pages: 208
and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Genzyme Corporation - Brief company overview including business description, key information and facts, and its
Global Markets Direct, Nov 2010, Pages: 208
and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Genzyme Corporation - Brief company overview including business description, key information and facts, and its
CurrentPartnering, Jan 2010, Pages: 57
The Partnering Agreements with Genzyme 2010 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.
This report provides all
Aruvian's R'search, July 2010, Pages: 60
Analysis of Genzyme Corporation. A complete and comprehensive analysis of Genzyme Corporation, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry
GlobalData, April 2011, Pages: 53
Genzyme Corporation (GENZ) - Financial and Strategic SWOT Analysis Review
Summary
Genzyme Corporation (Genzyme) is a biotechnology company which is principally engaged in developing and applying
Decision Resources, Inc., June 2010, Pages: 39
of two novel ERTs. Genzyme’s strategy in the Gaucher’s disease marketplace has been comprehensive and successful; the company can be said to be a model for other companies attempting to carve a treatment
Datamonitor, Aug 2010, Pages: 98
Introduction
This analysis examines the historical and forecast performance for Genzyme in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio
GlobalData, May 2011, Pages: 28
Genzyme Corporation (GENZ) - Product Pipeline Analysis
Summary
Genzyme Corporation (Genzyme), a subsidiary of Sanofi-aventis, is a biotechnology company which is principally engaged in developing
GlobalData, Dec 2011, Pages: 184
.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage
Cutting Edge Information, Feb 2010, Pages: 606
and promotion
- Decision support
- Medical affairs
- Market access
Analysis of Average Brand Spending by Time Period:
- Pre-clinical to Phase 2
- Phase 3a
- Phase 3b
- First year on the market Companies
Global Industry Analysts, Inc., Jan 2011, Pages: 442
Market Analysis for Gene
Therapy - Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart)
COMPETITIVE LANDSCAPE
Total Companies Profiled: 100 (including
GBI Research, Feb 2010, Pages: 181
“Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline”, which provides an insight into the global biotechnology industry and analyzes
GlobalData, May 2011, Pages: 5
Sanofi-Aventis Acquires Genzyme Corporation for $20 billion - Deal Analysis from GlobalData
Summary
Following acquisition by Sanofi-Aventis for about $20 billion, Genzyme Corporation will become
Wright Investors' Service, Feb 2012, Pages: 44
versus Biogen IDEC Inc., Mylan Inc and Allergan, Inc.. The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company Valuations (Price/Earnings, Price
